Scarica l'app Stockscreener
33.31
2.37%
-0.81
Dopo l'orario di chiusura:
33.30
-0.01
-0.03%
Precedente Chiudi:
$34.12
Aprire:
$34.68
Volume 24 ore:
270.27K
Relative Volume:
0.68
Capitalizzazione di mercato:
$625.45M
Reddito:
-
Utile/perdita netta:
$-67.30M
Rapporto P/E:
-8.651
EPS:
-3.8504
Flusso di cassa netto:
$-62.65M
1 W Prestazione:
-7.14%
1M Prestazione:
+49.51%
6M Prestazione:
+87.98%
1 anno Prestazione:
+41.68%
Intervallo 1D:
$31.39
$34.68
Intervallo di 1 settimana:
$31.39
$35.80
Portata 52W:
$13.70
$36.03
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Nome
Tectonic Therapeutic Inc
Settore
Industria
Telefono
(339) 666-3320
Indirizzo
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
33.31 | 625.45M | 0 | -67.30M | -62.65M | -3.8504 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-09-03 | Iniziato | Oppenheimer | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-21 | Iniziato | Mizuho | Outperform |
| 2024-11-20 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | TD Cowen | Buy |
| 2023-12-18 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-05 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-27 | Iniziato | Needham | Buy |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-03-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2019-04-05 | Iniziato | Janney | Buy |
| 2018-10-10 | Iniziato | Guggenheim | Buy |
| 2018-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-17 | Iniziato | H.C. Wainwright | Buy |
| 2018-07-16 | Iniziato | Wedbush | Outperform |
| 2018-07-16 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Tectonic Therapeutic Inc Borsa (TECX) Ultime notizie
Gains Report: Can Tectonic Therapeutic Inc outperform under higher oil prices2026 Gainers & Long-Term Capital Growth Strategies - baoquankhu1.vn
Tectonic Therapeutic (TECX) to Release Earnings on Thursday - MarketBeat
TECX: TX45 and TX2100 advance in key indications, with pivotal data expected by early 2027 - TradingView
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Insider Sell: Marcella Ruddy Sells Shares of Tectonic Therapeuti - GuruFocus
Peter Mcnamara Sells 6,262 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 10,000 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) CSO sells shares after exercising options - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Shares Down 9.8%Should You Sell? - MarketBeat
Stocks showing market leadership: Tectonic Therapeutic earns 96 RS rating - MSN
Published on: 2026-03-08 21:54:41 - baoquankhu1.vn
Aug Breakouts: Can Tectonic Therapeutic Inc. lead its sector in growthMarket Activity Recap & Community Driven Trade Alerts - baoquankhu1.vn
Published on: 2026-03-07 08:33:07 - baoquankhu1.vn
Unveiling Bumps: How Tectonic Therapeutic’s Recent Moves Affect the Market - timothysykes.com
Peter Mcnamara Sells 1,650 Shares of Tectonic Therapeutic (NASDAQ:TECX) Stock - MarketBeat
Insider Selling: Tectonic Therapeutic (NASDAQ:TECX) Insider Sells 1,649 Shares of Stock - MarketBeat
Tectonic Therapeutic (TECX) grants options and RSUs to CBO - Stock Titan
Tectonic Therapeutic (TECX) CMO receives RSU and stock option awards - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Hits New 12-Month HighHere's Why - MarketBeat
TECX SEC FilingsTectonic Therapeutic Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 11.4%What's Next? - MarketBeat
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Tectonic Therapeutic to Participate in March Investor Conferences - Bitget
Quarterly Risk: Is Tectonic Therapeutic Inc stock forming a cup and handleJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - baoquankhu1.vn
Biotech Tectonic to hold March investor fireside chats and one-on-one meetings - Stock Titan
TECX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Promising Biotech with a Potential 227% Upside - DirectorsTalk Interviews
Chen Yu and TCG report 6.2% stake in Tectonic Therapeutic (NASDAQ: TECX) - Stock Titan
Tectonic Therapeutics' Q4 Net Loss Widens; Phase 2 APEX Trial Data Due In 2026 - Nasdaq
TECX Should I Buy - Intellectia AI
TECX: Strong cash position and advancing clinical pipeline, with key trial results expected in 2026 - TradingView
Tectonic Therapeutic, Inc. Reports Positive Phase 1b Results for TX45 in Pulmonary Hypertension and Advances TX2100 into Phase 1a Trial for Hereditary Hemorrhagic Telangiectasia - Quiver Quantitative
TECXForm 8-KCurrent report - ADVFN Ltd
Tectonic Therapeutic, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewswire
Tectonic drug cuts heart-lung pressure 29%, backed by cash into 2028 - Stock Titan
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
Tectonic Therapeutic, Inc.Common Stock (NQ: TECX - The Chronicle-Journal
Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins - MarketBeat
Tectonic Therapeutic Announces Leadership Transition and New Chair - TipRanks
Insider Trends: Is now the right time to enter Tectonic Therapeutic IncDollar Strength & Daily Entry Point Alerts - baoquankhu1.vn
Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board - citybiz
Tectonic Therapeutic appoints François Nader as chair and independent director of the board - marketscreener.com
Tectonic Therapeutic Appoints François Nader As Chair And Independent Director Of The Board - TradingView
Tectonic Therapeutic Appoints Francois Nader, M.D., as Chair and Independent Director of the Board - Bitget
Tectonic Therapeutic, Inc. Announces Board and Committees Changes - marketscreener.com
Can Tectonic Therapeutic Inc. lead its sector in growthDividend Hike & Entry Point Confirmation Alerts - mfd.ru
Aberdeen Group plc Takes $5.59 Million Position in Tectonic Therapeutic, Inc. $TECX - MarketBeat
What are Tectonic Therapeutic Inc.’s technical support levels2025 Winners & Losers & Community Consensus Trade Signals - mfd.ru
Is Tectonic Therapeutic Inc. stock a smart retirement pickJuly 2025 Gainers & Free Community Consensus Stock Picks - mfd.ru
Market Outlook: Will KINS stock hit new highs in YEAREarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
Tectonic Therapeutic Inc Azioni (TECX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):